Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A solitary plasmacytoma that arises from the chest wall.
No clinical trials have been registered for solitary plasmacytoma of chest wall.
9 publications have been identified in PubMed for solitary plasmacytoma of chest wall. Research spans Case Report / Case Series (78%) and Review / Meta-Analysis (22%).
Fang Z (2026). [PMID: 41822898](https://pubmed.ncbi.nlm.nih.gov/41822898/). *Front Med (Lausanne)*. [Case Report / Case Series]
Imataki O (2026). [PMID: 41874105](https://pubmed.ncbi.nlm.nih.gov/41874105/). *Hematol Rep*. [Case Report / Case Series]
Msemo R (2025). [PMID: 41425404](https://pubmed.ncbi.nlm.nih.gov/41425404/). *Ann Thorac Surg Short Rep*. [Case Report / Case Series]
Kitamura S (2025). [PMID: 39907148](https://pubmed.ncbi.nlm.nih.gov/39907148/). *Cancer Rep (Hoboken)*. [Review / Meta-Analysis]
AbuGhannam SI (2025). [PMID: 40061166](https://pubmed.ncbi.nlm.nih.gov/40061166/). *Leuk Res Rep*. [Case Report / Case Series]
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 5:41 PM UTC
Alexieva M (2025). [PMID: 40918783](https://pubmed.ncbi.nlm.nih.gov/40918783/). *Cureus*. [Case Report / Case Series]
Citak S (2025). [PMID: 39854804](https://pubmed.ncbi.nlm.nih.gov/39854804/). *J Surg Res*. [Case Report / Case Series]
Möller K (2025). [PMID: 39857060](https://pubmed.ncbi.nlm.nih.gov/39857060/). *Diagnostics (Basel)*. [Review / Meta-Analysis]
AI-curated news mentioning solitary plasmacytoma of chest wall
Updated Jul 22, 2026
The International Myeloma Working Group has released updated recommendations for diagnosing and managing solitary plasmacytomas. These guidelines aim to standardize care and improve outcomes for patients with this rare condition.